Release of biologically functional interferon-alpha from a nanochannel delivery system

Keyphrases

• Interferon-α (IFN-α) 100%
• Delivery System 100%
• Nanochannel 100%
• Interferon alpha-2b 100%
• Tumor Microenvironment 66%
• Radiation Therapy 33%
• Melanoma 33%
• Tumor Growth 33%
• Small Molecules 33%
• Metastatic Melanoma 33%
• Malignant Melanoma 33%
• Antitumor Agents 33%
• Metastatic Renal Cell Carcinoma (mRCC) 33%
• Oncologists 33%
• Immune Regulation 33%
• Nanodevices 33%
• Close Proximity 33%
• Host Immune Response 33%
• Systemic Administration 33%
• Minimally Invasive Procedures 33%
• Clinic Visits 33%
• Drug Delivery Platform 33%
• Zero-order Release 33%
• Silicon-based 33%
• Local Injection 33%
• Human Melanoma Cells 33%
• Inconvenience 33%
• Unresectable Tumor 33%
• Antitumor Compounds 33%
• Diminutive 33%
• Radiation Chemotherapy 33%

Medicine and Dentistry

• Interferon Alfa 100%
• Interferon Alfa 2b 100%
• Nanochannel 100%
• Melanoma 66%
• Tumor Microenvironment 66%
• Tumor Progression 33%
• In Vitro 33%
• Radiation Therapy 33%
• Metastatic Melanoma 33%
• Anticarcinogen 33%
• Cosmetics 33%
• Kidney Metastasis 33%
• Acetylsalicylic Acid 33%
• Oncologist 33%
• Immunocompetent Cell 33%
• Systemic Administration 33%
• Minimally Invasive Procedure 33%
• Melanoma Cell Line 33%
• Tumor 33%
• Critical Structure 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Alpha Interferon 100%
• Melanoma 100%
• Nanochannel 100%
• Alpha2b Interferon 100%
• Tumor Microenvironment 66%
• Tumor Growth 33%
• Chemotherapy 33%
• Acetylsalicylic Acid 33%
• Anticarcinogen 33%
• Kidney Metastasis 33%
• Metastatic Melanoma 33%
• Systemic Administration 33%
• Cosmetics 33%